From coins to cancer therapy: Gold, silver and copper complexes targeting human topoisomerases.

Jessica Ceramella, Annaluisa Mariconda, Domenico Iacopetta, Carmela Saturnino, Alexia Barbarossa, Anna Caruso, Camillo Rosano, Maria Stefania Sinicropi, Pasquale Longo

Journal: Bioorganic & medicinal chemistry letters 2021;30(3):126905

PMID: 31874823

Abstract

Cancer is a complex issue and, even though the prevention basics and therapy have been implemented, it is still the second leading death cause worldwide. With the hope to discover new powerful and safer molecules to fight cancer, many researchers focused their attention on metal-based compounds, starting from the most famous and successfully employed anticancer drug, i.e. cisplatin. The current article aims to report the most recent discoveries about the use of gold, silver and copper complexes as antitumor agents, highlighting their influences on important enzymes, namely human topoisomerases. The latter are fundamental for the cell life and, if overexpressed, strongly implicated in cancer onset and progression. The identification of lead complexes targeting human topoisomerases and gifted with the appropriate chemical and pharmacological properties represents a fecund starting point to obtain new and more effective anticancer molecules.

Copyright © 2019 Elsevier Ltd. All rights reserved.

Address: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, CS, Italy.; Department of Science, University of Basilicata, 85100 Potenza, Italy.; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, CS, Italy. Electronic address: [email protected].; Biopolymers and Proteomics IRCCS, Ospedale Policlinico San Martino - IST, 16132 Genova, Italy.; Department of Biology and Chemistry, University of Salerno, 84084 Fisciano, Italy.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.